{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:54:48Z","timestamp":1792212888279,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bbrc.2011.11.023","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T05:57:21Z","timestamp":1320991041000},"page":"7-12","source":"Crossref","is-referenced-by-count":104,"title":["A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis"],"prefix":"10.1016","volume":"416","author":[{"given":"Amitabha","family":"Chattopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Jafurulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.11.023_b0330","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2011.11.023_b0010","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.112.18.2993","article-title":"Leishmania species: models of intracellular parasitism","volume":"112","author":"Alexander","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2011.11.023_b0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0020","unstructured":"World Health Organization. Website: http:\/\/www.who.int\/leishmaniasis\/en\/."},{"key":"10.1016\/j.bbrc.2011.11.023_b0335","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2011.11.023_b0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-3156.2006.01647.x","article-title":"Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India","volume":"11","author":"Singh","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bbrc.2011.11.023_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0169-4758(99)01431-3","article-title":"Leishmania\u2013HIV interaction: immunopathogenic mechanisms","volume":"15","author":"Wolday","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.bbrc.2011.11.023_b0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1471-4922(02)02352-8","article-title":"Interaction of Leishmania with the host macrophage","volume":"18","author":"Handman","year":"2002","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0169-4758(00)01692-6","article-title":"Leishmania\u2013host-cell interaction: complexities and alternative views","volume":"16","author":"Rittig","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.bbrc.2011.11.023_b0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.micro.55.1.453","article-title":"Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis","volume":"55","author":"Sacks","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0065","doi-asserted-by":"crossref","first-page":"R823","DOI":"10.1016\/S0960-9822(00)00788-0","article-title":"Microbial pathogenesis: lipid rafts as pathogen portals","volume":"10","author":"Rosenberger","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1286-4579(01)01423-X","article-title":"Caveolae as portals of entry for microbes","volume":"3","author":"Shin","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbrc.2011.11.023_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/smim.2000.0300","article-title":"Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack","volume":"13","author":"van der Goot","year":"2001","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2011.11.023_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-511X-4-10","article-title":"Role of cholesterol in parasitic infections","volume":"4","author":"Bansal","year":"2005","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0090","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1128\/IAI.73.12.7791-7796.2005","article-title":"Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells","volume":"73","author":"Goluszko","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2011.11.023_b0095","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/138945006779025455","article-title":"Lipid membrane; a novel target for viral and bacterial pathogens","volume":"7","author":"Hawkes","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbrc.2011.11.023_b0100","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.bbamem.2006.07.017","article-title":"Membrane rafts in host\u2013pathogen interactions","volume":"1758","author":"Riethm\u00fcller","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pt.2006.12.003","article-title":"Cholesterol: a potential therapeutic target in Leishmania infection?","volume":"23","author":"Pucadyil","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/BC20090138","article-title":"Host-cell lipid rafts: a safe door for micro-organisms?","volume":"102","author":"Vieira","year":"2010","journal-title":"Biol. Cell."},{"key":"10.1016\/j.bbrc.2011.11.023_b0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plipres.2006.02.002","article-title":"Role of cholesterol in the function and organization of G-protein coupled receptors","volume":"45","author":"Pucadyil","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbrc.2011.11.023_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-90-481-8622-8_1","article-title":"Cholesterol\u2013protein interaction: methods and cholesterol reporter molecules","volume":"51","author":"Gimpl","year":"2010","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbrc.2011.11.023_b0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-90-481-8622-8_16","article-title":"Membrane cholesterol in the function and organization of G-protein coupled receptors","volume":"51","author":"Paila","year":"2010","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbrc.2011.11.023_b0130","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.1089324","article-title":"Erythrocyte G protein-coupled receptor signaling in malarial infection","volume":"301","author":"Harrison","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2011.11.023_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molbiopara.2003.10.002","article-title":"Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis","volume":"133","author":"Pucadyil","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbrc.2005.11.062","article-title":"The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages","volume":"339","author":"Tewary","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.11.023_b0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","article-title":"Amphotericin B inhibits entry of Leishmania donovani into primary macrophages","volume":"399","author":"Paila","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.11.023_b0150","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1462-5822.2006.00695.x","article-title":"Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages","volume":"8","author":"Rodr\u00edguez","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/eri.10.78","article-title":"Current diagnosis and treatment of visceral leishmaniasis","volume":"8","author":"Mondal","year":"2010","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.bbrc.2011.11.023_b0160","first-page":"345","article-title":"Visceral leishmaniasis \u2013 current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbrc.2011.11.023_b0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/600105","article-title":"Highly effective oral amphotericin B formulation against murine visceral leishmaniasis","volume":"200","author":"Wasan","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0005-2736(86)90498-0","article-title":"The water and ionic permeability induced by polyene antibiotics across plasma membrane vesicles from Leishmania sp.","volume":"860","author":"Cohen","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0175","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2011.11.023_b0180","unstructured":"J.D. Dutcher, W. Gold, J.F. Pagano, J. Vandepatte, Amphotericin B, its production and its salts, US patent 2908,611, 1959."},{"key":"10.1016\/j.bbrc.2011.11.023_b0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5173(97)00417-1","article-title":"Amphotericin B toxicity and lethality: a tale of two channels","volume":"162","author":"Cohen","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2011.11.023_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","article-title":"Amphotericin B","volume":"68","author":"Lemke","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0195","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1128\/AAC.36.9.1978","article-title":"Activity of amphotericin B cholesterol dispersion (amphocil) in experimental visceral leishmaniasis","volume":"36","author":"Berman","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2011.11.023_b0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10611869708995847","article-title":"Release of amphotericin B from delivery systems and its action against fungal and mammalian cells","volume":"4","author":"Legrand","year":"1997","journal-title":"J. Drug Target"},{"key":"10.1016\/j.bbrc.2011.11.023_b0205","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.47.12.3774-3779.2003","article-title":"Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B","volume":"47","author":"Larabi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2011.11.023_b0210","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1002\/anie.200501613","article-title":"Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes","volume":"44","author":"Wu","year":"2005","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.bbrc.2011.11.023_b0215","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jac\/dkr002","article-title":"Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes","volume":"66","author":"Prajapati","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2011.11.023_b0220","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"issue":"Suppl. B","key":"10.1016\/j.bbrc.2011.11.023_b0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/28.suppl_B.111","article-title":"Liposomal amphotericin B in the treatment of visceral leishmaniasis","volume":"28","author":"Croft","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2011.11.023_b0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0240","unstructured":"M.D. Houslay, K.K. Stanley, Dynamics of biological membranes: influence on synthesis, structure and function, John Wiley, New York, 2009, p. 289."},{"key":"10.1016\/j.bbrc.2011.11.023_b0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-4157(86)90002-X","article-title":"How do the polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0165-6147(96)01012-7","article-title":"Amphotericin B: new life for an old drug","volume":"17","author":"Hartsel","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2011.11.023_b0255","doi-asserted-by":"crossref","first-page":"15875","DOI":"10.1021\/jp905133f","article-title":"On the possibility of the amphotericin B\u2013sterol complex formation in cholesterol- and ergosterol-containing lipid bilayers: a molecular dynamics study","volume":"113","author":"Neumann","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbrc.2011.11.023_b0260","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/mol.52.4.560","article-title":"Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation","volume":"52","author":"Baginski","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0265","doi-asserted-by":"crossref","first-page":"655","DOI":"10.18388\/abp.2005_3426","article-title":"Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic","volume":"52","author":"Baginski","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0005-2736(74)90332-0","article-title":"Polyene antibiotic\u2013sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes: III. Molecular structure of the polyene antibiotic\u2013cholesterol complexes","volume":"339","author":"De Kruijff","year":"1974","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01868444","article-title":"Single-length and double-length channels formed by nystatin in lipid bilayer membranes","volume":"80","author":"Kleinberg","year":"1984","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-010-9313-y","article-title":"Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects","volume":"238","author":"Cohen","year":"2010","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0285","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.9.4.512","article-title":"Carrier effects on biological activity of amphotericin B","volume":"9","author":"Brajtburg","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2011.11.023_b0290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.qco.0000191508.48481.f4","article-title":"Comparison of the efficacy and pharmacology of formulations of amphotericin B used in treatment of leishmaniasis","volume":"18","author":"Barratt","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2011.11.023_b0295","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/AAC.46.3.834-840.2002","article-title":"Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2011.11.023_b0300","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbamem.2004.03.010","article-title":"Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus","volume":"1663","author":"Pucadyil","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0305","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-2736(82)90103-1","article-title":"Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols","volume":"685","author":"Readio","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.11.023_b0315","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1021\/bi800334p","article-title":"Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance","volume":"47","author":"Mouri","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2011.11.023_b0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0166-6851(86)90001-0","article-title":"Mechanism of action of amphotericin B on Leishmania donovani promastigotes","volume":"19","author":"Saha","year":"1986","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbrc.2011.11.023_b0325","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/AAC.30.6.847","article-title":"Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys","volume":"30","author":"Berman","year":"1986","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11020225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11020225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:56:26Z","timestamp":1639623386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11020225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":65,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0006291X11020225"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.11.023","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}